Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$242.49 - $301.46 $1,454 - $1,808
-6 Reduced 0.52%
1,143 $281,000
Q2 2022

Aug 15, 2022

BUY
$224.73 - $338.64 $21,349 - $32,170
95 Added 9.01%
1,149 $284,000
Q1 2022

May 11, 2022

BUY
$277.25 - $366.29 $7,763 - $10,256
28 Added 2.73%
1,054 $349,000
Q4 2021

Feb 14, 2022

SELL
$300.63 - $371.35 $6,914 - $8,541
-23 Reduced 2.19%
1,026 $369,000
Q3 2021

Nov 15, 2021

BUY
$310.19 - $376.2 $8,995 - $10,909
29 Added 2.84%
1,049 $341,000
Q2 2021

Aug 16, 2021

BUY
$262.71 - $351.17 $2,101 - $2,809
8 Added 0.79%
1,020 $318,000
Q1 2021

May 17, 2021

BUY
$285.92 - $355.13 $289,351 - $359,391
1,012 New
1,012 $323,000
Q4 2019

Feb 14, 2020

SELL
$159.31 - $223.54 $214,909 - $301,555
-1,349 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$175.89 - $279.23 $71,763 - $113,925
408 Added 43.36%
1,349 $240,000
Q2 2019

Aug 12, 2019

SELL
$250.96 - $284.94 $22,084 - $25,074
-88 Reduced 8.55%
941 $245,000
Q1 2019

May 15, 2019

BUY
$276.39 - $362.25 $284,405 - $372,755
1,029 New
1,029 $294,000
Q3 2018

Nov 14, 2018

SELL
$354.53 - $449.75 $238,598 - $302,681
-673 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$278.07 - $446.21 $187,141 - $300,299
673 New
673 $275,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Veritable, L.P. Portfolio

Follow Veritable, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.